TB Research

VapC12 ribonuclease toxin modulates host immune response during <i>Mycobacterium tuberculosis</i> infection

Shaifali Tyagi, Srikanth Sadhu, Taruna Sharma, Abhijit Paul, Manitosh Pandey, Vaibhav Kumar Nain, Deepak Kumar Rathore, Samrat Chatterjee, et al. (10 authors)

bioRxiv (Cold Spring Harbor Laboratory) · 2023-08

Abstract

Abstract Mechanistic understanding of antibiotic persistence is a prerequisite in controlling the emergence of MDR cases in Tuberculosis (TB). We have reported that the cholesterol-induced activation of VapC12 ribonuclease is critical for disease persistence in TB. In this study, we observed that relative to the wild type, mice infected with Δ vapC12 induced a proinflammatory response, had a higher pathogen load, and responded better to the anti-TB treatment. In a high-dose infection model, all the mice infected with Δ vapC12 succumbed early to the disease. Finally, we reported that the above phenotype of Δ vapC12 was dependent on the presence of the TLR4 receptor. Overall, the data suggest that the inability of Δ vapC12 to resolve neutrophil-mediated inflammation reduced bacterial killing by altering the T-cell response. In conclusion, our findings suggest the role of the VapC12 toxin in modulating the host’s innate immune response in ways that favor the long-term survival of the pathogen inside the host.

MeSH terms

  • Immune system
  • Biology
  • Pathogen
  • Innate immune system
  • Proinflammatory cytokine
  • Mycobacterium tuberculosis
  • Immunology
  • Microbiology
  • Ribonuclease
  • TLR4
  • Inflammation
  • Tuberculosis
  • Host (biology)
  • Pattern recognition receptor
  • Disease